Atlas Venture Associates Opportunity I, LLC, 10% Owner at Ikena Oncology, Inc. (IKNA), sold 46,597 shares at $14.00 ($688K) on 2021-12-14, disclosed to the SEC on 2021-12-14.
Open-market sale of $688k IKNA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.03 | 11,989 | $180K | 26.2% |
| 2 | $15.03 | 11,989 | $180K | 26.2% |
| 3 | $14.64 | 8,330 | $122K | 17.7% |
| 4 | $14.64 | 8,330 | $122K | 17.7% |
| 5 | $14.00 | 5,959 | $83K | 12.1% |
| Total | $14.76 avg | 46,597 |
| $688K |
| 100% |
| Filing → |
| KYMR | SELL | 2022-12-16 | $23.9M | — | Filing → |
| GBIO | SELL | 2021-06-23 | $9.3M | — | Filing → |
| AKRO | BUY | 2019-06-25 | $4.3M | — | Filing → |